Brivace 50mg Tablet – Reliable Add-On Therapy for Partial-Onset Seizures in Epilepsy
Brivace 50mg Tablet – Reliable Add-On Therapy for Partial-Onset Seizures in Epilepsy
Brivace 50mg Tablet – Reliable Add-On Therapy for Partial-Onset Seizures in Epilepsy
Description
Brivace 50mg Tablet – Fast-Acting Brivaracetam for Improved Seizure Control
Brivace 50mg Tablet contains Brivaracetam 50mg, a next-generation antiepileptic that selectively binds to synaptic vesicle protein 2A (SV2A) to reduce excessive neuronal firing. It is prescribed as an adjunctive treatment for partial-onset (focal) seizures, with or without secondary generalization, in adults and adolescents aged 16 years and older with epilepsy. With rapid absorption, high bioavailability, and significantly fewer behavioral side effects than levetiracetam, Brivace 50mg is an excellent choice for patients needing better seizure control or those who experienced irritability on older SV2A modulators.
